Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China flag China · Delayed Price · Currency is CNY
139.31
+4.31 (3.19%)
Jun 30, 2025, 2:45 PM CST

Beijing Hotgen Biotech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Operating Revenue
482.12505.01544.623,5325,307511.67
Upgrade
Other Revenue
5.895.893.2224.4162.651.86
Upgrade
488.02510.9547.843,5575,369513.53
Upgrade
Revenue Growth (YoY)
5.85%-6.74%-84.60%-33.76%945.54%144.06%
Upgrade
Cost of Revenue
258.78257.18211.721,7662,254189.95
Upgrade
Gross Profit
229.24253.72336.111,7903,116323.59
Upgrade
Selling, General & Admin
296.74289.77258.6483.58404.26161.44
Upgrade
Research & Development
111.07113.31132.88191.14131.9247.61
Upgrade
Other Operating Expenses
2.483.453.589.25.040.88
Upgrade
Operating Expenses
411.65407.9381.66695.26541.92211.13
Upgrade
Operating Income
-182.41-154.18-45.551,0952,574112.46
Upgrade
Interest Expense
-0.45-0.45-1.01-2.32-1.27-0.45
Upgrade
Interest & Investment Income
66.0532.8539.5934.5234.268.42
Upgrade
Currency Exchange Gain (Loss)
-0.78-0.784.314.95-14.641.7
Upgrade
Other Non Operating Income (Expenses)
0.660.24-1.273.31-4.82-0
Upgrade
EBT Excluding Unusual Items
-116.94-122.32-3.921,1352,587122.12
Upgrade
Gain (Loss) on Sale of Investments
-42.1-9.36-23.687.523.12-
Upgrade
Gain (Loss) on Sale of Assets
-3.39-1.63-0.64-0.34-14.21-0.18
Upgrade
Asset Writedown
-60.87-60.85-41.79-70.06-8.51-0.14
Upgrade
Other Unusual Items
6.216.2985.022.6314.225.62
Upgrade
Pretax Income
-217.09-187.8714.991,0752,582127.42
Upgrade
Income Tax Expense
6.958.06-1.73150.1379.4416.13
Upgrade
Earnings From Continuing Operations
-224.04-195.9416.71925.122,202111.3
Upgrade
Minority Interest in Earnings
3.974.9312.2119.62-16.610.77
Upgrade
Net Income
-220.07-19128.92944.742,186112.07
Upgrade
Net Income to Common
-220.07-19128.92944.742,186112.07
Upgrade
Net Income Growth
---96.94%-56.78%1850.41%230.80%
Upgrade
Shares Outstanding (Basic)
949288919292
Upgrade
Shares Outstanding (Diluted)
949288929292
Upgrade
Shares Change (YoY)
8.41%4.59%-3.88%-0.14%-0.12%23.13%
Upgrade
EPS (Basic)
-2.33-2.070.3310.3323.751.22
Upgrade
EPS (Diluted)
-2.33-2.070.3310.2823.751.22
Upgrade
EPS Growth
---96.81%-56.72%1852.80%168.66%
Upgrade
Free Cash Flow
-47.5-88.57-461.9413.542,246-7.65
Upgrade
Free Cash Flow Per Share
-0.50-0.96-5.234.5024.40-0.08
Upgrade
Dividend Per Share
--0.200-3.3781.014
Upgrade
Dividend Growth
----233.34%400.00%
Upgrade
Gross Margin
46.97%49.66%61.35%50.34%58.03%63.01%
Upgrade
Operating Margin
-37.38%-30.18%-8.31%30.79%47.93%21.90%
Upgrade
Profit Margin
-45.09%-37.39%5.28%26.56%40.71%21.82%
Upgrade
Free Cash Flow Margin
-9.73%-17.34%-84.31%11.63%41.82%-1.49%
Upgrade
EBITDA
-92.3-69.8415.661,1842,631141.61
Upgrade
EBITDA Margin
-18.91%-13.67%2.86%33.30%49.00%27.57%
Upgrade
D&A For EBITDA
90.1184.3361.289.3957.529.15
Upgrade
EBIT
-182.41-154.18-45.551,0952,574112.46
Upgrade
EBIT Margin
-37.38%-30.18%-8.31%30.79%47.93%21.90%
Upgrade
Effective Tax Rate
---13.96%14.70%12.66%
Upgrade
Revenue as Reported
488.02510.9547.843,5575,369513.53
Upgrade
Advertising Expenses
-15.5913.3855.0868.417.17
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.